AETOSWire - AETOSWire

العربية

Home
About us
- About
- Partners
- Blog
Services
Newsroom
- All Press Releases
- Multimedia Newsroom
Contact
Account

العربية

Home
About us
- About
- Partners
- Blog
Services
Newsroom
- All Press Releases
- Multimedia Newsroom
Contact
Account

العربية

NewsRoom

Home
NewsRoom

Newsroom
Multimedia Newsroom

Thursday, 07. March 2024

Two Year Sustained Cognitive Benefits of Hydromethylthionine Mesylate (HMTM) Indicated...

Monday, 05. February 2024

TauRx to Present Two-Year Data from Phase III Trial of...

Monday, 17. July 2023

TauRx’s Hydromethylthionine Mesylate (HMTM) Demonstrates Significant Reduction in Neurodegeneration in...

Subscribe to our Newsletter

Enter your email and stay updated

www.satellite-stars.online

About

AETOSWire distributes your news swiftly across your target audiences to every corner of the world with the latest state-of-the-art technology and innovative solutions that give you the competitive edge you need to get ahead of the competition.

Address

Dubai Media City, Building 1, 3rd Floor, Office 312 P.O. Box 502342 Dubai, United Arab Emirates

+971 4 55 77 007

+971 4 55 77 008

info@aetoswire.com

Quick Links

About us

Services

Newsroom

My Account

Privacy
Terms Of Use
Sitemap

Your experience on this site will be improved by allowing cookies. Cookie Policy

NewsRoom

Two Year Sustained Cognitive Benefits of Hydromethylthionine Mesylate (HMTM) Indicated...

TauRx to Present Two-Year Data from Phase III Trial of...

TauRx’s Hydromethylthionine Mesylate (HMTM) Demonstrates Significant Reduction in Neurodegeneration in...

Search...

Search...